✦ LIBER ✦

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

✍ Scribed by Eva Martinez-Balibrea; Albert Abad; Enrique Aranda; Javier Sastre; Jose Luis Manzano; Eduardo Díaz-Rubio; Auxiliadora Gómez-España; Jorge Aparicio; Teresa García; Inmaculada Maestu; Anna Martínez-Cardús; Alba Ginés; Elisabet Guino

Book ID: 116429641
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 249 KB
Volume: 44
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2008.03.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetic prediction of clinical o

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

✍ Paré, L; Marcuello, E; Altés, A; Río, E del; Sedano, L; Salazar, J; Cortés, A; B 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Pharmacogenetic prediction of clinical o

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

✍ Paré, L; Marcuello, E; Altés, A; del Río, E; Sedano, L; Salazar, J; Cortés, A; B 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 44 KB

3011 ORAL Role of Thymidylate synthase –

3011 ORAL Role of Thymidylate synthase –6bp/1494 deletion polymorphism in capecitabine or 5-fluorouracil (5FU) selection in first line oxaliplatin-based chemotherapy in advanced colorectal cancer

✍ E. Martinez-Balibrea; E. Aranda; J.L. Manzano; J. Sastre; J. Aparicio; T. García 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A multicenter phase II study of biweekly

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

✍ Chao, Yee; Hsieh, Jan-Sing; Yeh, Hsien-Tang; Su, Yu-Chieh; Wu, Cheng-Chung; Chen 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 291 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

✍ Hideo Baba; Naoko Hayashi; Yasunori Emi; Yoshihiro Kakeji; Akinori Egashira; Eij 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 143 KB

A randomized phase II study to compare o

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

✍ Cristina Gravalos, Antonieta Salut, Carlos García-Girón, Rocío García-Carbonero, 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 294 KB